Qiagen N.V.

NYSE:QGEN

Medical - Diagnostics & Research

Healthcare
$49.56 -0.96%

-$0.35 today

Market cap
$10.23B
Beta
0.66
P/E (TTM)
18.6
EPS (TTM)
$1.94
Dividend yield
0.69%
52W Low $32.53High $57.82

Volume 4.26M

Average 2.07M

Income Statement

Follow revenue through to earnings.

Revenue

$2.09B

FY 2025 · Annual

+5.7% YoY

Operating Income

$520.31M

FY 2025 · Annual

+432.5% YoY

Net Income

$424.88M

FY 2025 · Annual

+408.3% YoY

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue2.25B2.14B1.97B1.98B2.09B
Cost of Revenue800.84M756.96M731.62M1.01B798.5M
Gross Profit1.45B1.38B1.23B967.35M1.29B
Gross Margin64.4%64.7%62.8%48.9%61.8%
Research & Development189.96M189.86M198.51M193.49M187.52M
Selling, General & Admin584.47M603.95M579.17M564.36M583.67M
Operating Expenses820.74M853.1M823.75M869.64M771.19M
Depreciation & Amortization214.93M208.4M205.34M203.27M193.75M
EBITDA895.24M779.36M688.56M368.26M717.27M
EBITDA Margin39.8%36.4%35.0%18.6%34.3%
Operating Income630.08M531.46M409.94M97.71M520.31M
Operating Margin28.0%24.8%20.9%4.9%24.9%
Interest Income9.56M32.76M78.99M68.02M64.32M
Interest Expense54.48M58.36M53.41M43.84M33.26M
Other Income / Expenses(4.25M)(18.86M)19.87M23.44M(30.04M)
Income Before Tax625.83M512.6M429.81M121.15M490.27M
Pre-Tax Margin27.8%23.9%21.9%6.1%23.5%
Income Tax Expense113.23M89.39M88.51M37.56M65.39M
Net Income512.6M423.21M341.3M83.59M424.88M
Net Margin22.8%19.8%17.4%4.2%20.3%
EPS (Basic)2.522.081.670.392.04
EPS (Diluted)2.472.051.650.382.04
Weighted Avg Shares221.14M220.75M217.49M216.44M207.94M
Weighted Avg Shares (Diluted)225.07M223.23M217.49M218.48M207.94M

QGEN Earnings Waterfall · TTM

NYSE:QGEN · Revenue to Net Income

Key Ratios

EPS$1.95
Gross Margin61.9%
Net Margin19.4%
P/E Ratio22.8
P/S Ratio17.1

Analysis

$2.1B of revenue converted into $409.3M of net income for the selected period. Gross margin is 61.9% and net margin is 19.4%, showing how much revenue survives after costs and taxes. EPS is $1.95, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
6-K6-K filingNov 6, 2026
SC 13G/ASC 13G/A filingNov 6, 2026
6-K6-K filingNov 6, 2026
SC TO-CSC TO-C filingOct 28, 2026
6-K6-K filingOct 23, 2026

How much revenue does QGEN generate?

Qiagen N.V. (QGEN) reported $2.09B of revenue in fiscal 2025.

Is QGEN profitable?

Qiagen N.V. (QGEN) reported $424.88M of net income, with a net margin of 20.3%.